Proceeds will support continued commercial expansion, operational scale-up, clinical study execution, and product development * Clinical oncology ...
The San Diego company says its blood test can detect pancreatic cancer when curative surgery may still be an option.
KYOTO--Researchers here say they developed a highly accurate method to detect early signs of pancreatic cancer using artificial intelligence (AI).
ClearNote Health secures $52 million to scale early cancer detection and expand global clinical and commercial operations.
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test ...
Healthcare Asia Magazine on MSN
Biomarkers market set for 11% CAGR on early detection push
The market was valued at $26.48b in 2025. The global cancer biomarkers market is projected to grow at a compound annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results